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Abstract 22 
Predation of starter lactic acid bacteria such as Streptococcus thermophilus by bacteriophages 23 
is a persistent and costly problem in the dairy industry. CRISPR-mediated Bacteriophage 24 
Insensitive Mutants (BIMs), while straightforward to generate and verify, can quickly be 25 
overcome by mutant phages. The aim of this study was to develop a tool allowing the 26 
generation of derivatives of commercial S. thermophilus strains which are resistant to phage 27 
attack through a non-CRISPR-mediated mechanism, with the objective of generating BIMs 28 
exhibiting stable resistance  against a range of isolated lytic S. thermophilus phages. To 29 
achieve this, standard BIM generation was complemented by the use of the wild-type (WT) 30 
strain which had been transformed with an antisense mRNA-generating plasmid (targeting a 31 
crucial CRISPR-associated [cas] gene], in order to facilitate the generation of non-CRISPR-32 
mediated BIMs. Phage sensitivity assays suggest that non-CRISPR-mediated BIMs exhibit 33 
some advantages compared to CRISPR-mediated BIMs derived from the same strain. 34 
  35 
Importance: The outlined approach reveals the presence of a powerful host-imposed barrier 36 
for phage infection in S. thermophilus. Considering the detrimental economic consequences 37 
of phage infection in the dairy processing environment, the developed methodology has 38 
widespread applications, particularly where other methods may not be practical or effective 39 
in obtaining robust, phage-tolerant S. thermophilus starter strains.  40 
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Introduction 41 
Streptococcus thermophilus is a widely employed bacterium used for milk acidification and 42 
subsequent product texturizing, required for the manufacture of cheeses and yoghurts in the 43 
dairy industry (1). This process, however, can be disrupted, retarded or halted by contaminant 44 
(bacterio)phages, which present a persistent problem in dairy fermentations (2,  and reviewed 45 
by 3). Several approaches may be utilised in an attempt to mitigate this costly problem. These 46 
include: (i) starter rotational schemes (i.e. the rotation of strain sets with non-overlapping 47 
phage sensitivities), (ii) heat or chemical treatments of dairy plant equipment in order to 48 
reduce the phage burden (4), or (iii) generation of bacteriophage insensitive mutants (BIMs) 49 
of S. thermophilus starters for the incorporation into rotational schemes mentioned above. 50 
BIMs may be generated by one of several methods, including insertional mutagenesis (5), 51 
immunoselection combined with cell sorting (6), construction of mutant libraries followed by 52 
phage exposure (7), the secondary culture method (8), serial passaging in the presence of high 53 
titer phages (9, 10), or chemical mutagenesis (11-13) 54 
Generated BIMs should, ideally, be (i) robust, i.e. insensitive to a high level of and/or 55 
repeatedly introduced phages, (ii) resistant to a wide variety of genetically distinct phages, 56 
(iii) possess identical technological properties to the parent strain from which they were 57 
derived, and (iv) be derived from parent S. thermophilus strains at a high frequency, and (v) 58 
easy to characterise both genetically and phenotypically. In the context of robustness, defined 59 
here as the ability of a BIM to survive high titer phage exposure, repeated phage challenges 60 
(such as the Heap-Lawrence test (14), and/or challenges using genetically distinct phages, the 61 
mechanism conferring resistance to the BIM may be relevant. Several S. thermophilus phage 62 
resistance systems have been documented. Restriction modification (R/M) systems are 63 
thought to be widespread in this species and are, for the most part, chromosomally encoded 64 
(15-19), with one described example of a complete, plasmid-encoded R/M system (20). A 65 
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lactococcal-derived R/M system was also shown to function in S. thermophilus when 66 
introduced using a compatible cloning vector (21). A lactococcal abortive infection (Abi) 67 
system was shown to function in S. thermophilus (22), and indeed, evidence of a native Abi 68 
system has been detected (23), though these systems are not well characterised in S. 69 
thermophilus. Superinfection exclusion (Sie) has also been described in prophages of S. 70 
thermophilus (24), although, considering the apparent rarity of resident prophages in the 71 
species (24, 25), prophage-encoded systems of this type are probably not widespread.  72 
The most widely characterised phage-resistance system in S. thermophilus is the 73 
clustered regularly interspaced short palindromic repeats (CRISPR), and their associated 74 
‘CRISPR-associated’, or cas, genes - together referred to as the ‘CRISPR-Cas system’ (26-75 
29),  first proven to be a phage-resistance mechanism by Barrangou and colleagues (30). Four 76 
distinct CRISPR-Cas systems have now been identified in S. thermophilus (31), of which two 77 
are known to actively provide phage immunity to this species  (this study, 26, 27) - namely 78 
CRISPR1-Cas and CRISPR3-Cas. Both of these systems are classified as ‘Type II-A’ 79 
systems, of which the cas components comprise cas9, cas1, cas2 and csn2 - each performing 80 
a specific function in the context of the system (32). 81 
These systems fundamentally act to digest incoming DNA using the product of the cas9 82 
gene the signature gene of the Type II-A group (33, 34)), which is essential for CRISPR-83 
based immunity (30, 35, 36). Segments (approximately 30 base pairs) of the foreign DNA 84 
(known as ‘spacers’) are incorporated into the chromosome at specific repeat-spacer loci in a 85 
mechanism which is believed to involve the product of the csn2 gene (30, 37), potentially in 86 
complex with Cas9, Cas1, and Cas2 (38). The Cas-encoding genes, as well as the repeat-87 
spacer loci are constitutively transcribed (18, 39), and the resultant ‘crRNA’ acts as a guide to 88 
particular Cas proteins to recognise and target subsequent incoming DNA. This process is 89 
reliant on the presence of an approximately 30 nucleotide DNA fragment on the phage 90 
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genome termed the protospacer (i.e., the specific sequence on the phage genome that is 91 
targeted by the CRISPR-Cas system; 40) as well as a short sequence flanking this target 92 
sequence, termed the protospacer adjacent motif or PAM (26, 40, 41).  93 
The presence of up to four distinct CRISPR-Cas systems in characterised S. 94 
thermophilus strains (31) suggests that this system has been instrumental in shaping the 95 
dynamics of the phage-host relationship on an evolutionary scale. The efficiency and 96 
specificity of this immune system is matched only by the phages’ adaptive response to it. 97 
Deveau and colleagues (40) showed that phages can rapidly overcome CRISPR-mediated 98 
resistance through mutations in either the target protospacer or adjacent PAM. Similar results 99 
were reported more recently by Sun and colleagues (42). Thus, in order to develop robust 100 
BIMs, it may be prudent to maximise the number of systems targeting the incoming phage, 101 
an approach which has recently been shown to significantly increase phage resistance by 102 
combining the protective effect of a CRISPR-Cas system with that of a functional R/M 103 
system (43). In order to facilitate the selection of non-CRISPR-mediated BIMs, we 104 
endeavoured to inactivate (by mRNA silencing) purportedly crucial genes in the CRISPR1-105 
Cas and CRISPR3-Cas systems, namely cas9 and csn2.  106 
Here we present a method whereby BIMs of S. thermophilus, whose phage resistance is 107 
mediated by a CRISPR-independent mechanism, may be selected for. This method relies on 108 
antisense mRNA-producing plasmids, a method previously used to confer phage resistance to 109 
Lactococcus lactis and S. thermophilus by targeting intracellular phage replication (44-47). 110 
Here, the principle of anti-sense-mediated ‘CRISPR-Cas silencing’ was validated by 111 
targeting the cas9-1 (CRISPR1-associated) or cas9-3 (CRISPR3-associated) genes of three 112 
BIMs, thereby inhibiting phage resistance conferred by a previously acquired spacer. In order 113 
to generate BIMs of a given S. thermophilus strain that are resistant to phages by the action of 114 
a non-CRISPR-mediated mechanism, an anti-sense plasmid construct simultaneously 115 
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silencing both the csn2 gene of the CRISPR1-Cas system and its analogue in the CRISPR3-116 
Cas system was employed. 117 
118 
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Materials and methods 119 
Isolation, growth and storage of bacterial strains and bacteriophages 120 
Bacterial strains and bacteriophages applied in this study are listed in Table 1. S. 121 
thermophilus strains were routinely grown from 20 % Reconstituted Skimmed Milk (RSM) 122 
stocks or from a single colony overnight at 42 °C in M17 Broth (Oxoid, Hampshire, U.K.) 123 
supplemented with 0.5 % lactose (LM17) or on plates containing 10 g/L technical agar 124 
(Merck, Darmstadt, Germany). Phages were isolated from industrial whey samples and 125 
purified by two rounds of single plaque purification as previously described (48). Phage 126 
enumeration assays were performed as previously described (49) using LM17 broth 127 
supplemented with 0.25 % glycine (Oxoid, U.K.), 10 mM CaCl2 (Oxoid, U.K.) and either 10 128 
g/L (solid agar base) or 4 g/L (semi-solid overlay) technical agar. L. lactis NZ9000 (50) was 129 
maintained as above with the following modifications: overnight (ON) cultures were grown 130 
at 30 °C with the substitution of glucose (Sigma-Aldrich, St. Louis, MO, U.S.A.) instead of 131 
lactose. All transformants were maintained as above with the addition of chloramphenicol 132 
(Cm; Sigma-Aldrich) to a final concentration of 5 µg/ml (L or GM17+Cm5). 133 
 134 
Bacteriophage Insensitive Mutant (BIM) generation and validation 135 
BIMs of S. thermophilus ST47795 (hereafter referred to as strain ‘STA’) and ST64985 136 
(hereafter referred to as strain ‘STB’) were generated by adding 300 µl fresh overnight 137 
bacterial culture and 10 µl undiluted phage lysate (at a titer of approximately 1 x 10
7
 pfu/ml) 138 
to 4 ml of semi-solid agar (as above), in a modification as outlined in a previously published 139 
plaque assay method (49). Colonies visibly growing in the semi-solid agar following 140 
overnight incubation (where the bacterial lawn failed to grow due to the presence of phages) 141 
were twice single-colony purified and subjected to phage challenge (as described above), and 142 
selected for further characterisation (as described below). In cases where an insufficient 143 
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number of BIMs were isolated using this method, the amount of culture and/or phage lysate 144 
added was increased, or the method repeated. Sensitivity of wild-type and derived BIMs to 145 
phages was determined using spot and/or plaque assays, as previously described (49). The 146 
relative efficiency of plaquing (EOP) of phages on wild-type strains and derived BIMs was 147 
determined by dividing the observed titer of the phage on a given BIM host by that on wild-148 
type strain (each plaque assay having been performed independently three times). 149 
All BIMs generated were subjected to PCR profiling to confirm their relatedness to the 150 
relevant parent strain from which they were derived by CRISPR locus sequencing (26). 151 
Primers applied in this study are listed in Table 2. CRISPR PCR conditions were as follows: 152 
95 °C x 10 min, followed by 30 cycles of 95 °C x 15 s, 55 °C x 15 s and 72 °C for either 2 153 
min 45 s (CRISPR1), 1 min (STB CRISPR2, 3 and 4), or 1 min 30 s (STA CRISPR2 and 3), 154 
with a final extension step of 72 °C for 10 min.  155 
PCR-generated products were visualised on a 1 % agarose (Fisher Scientific, USA) gel 156 
and purified using a JetQuick PCR purification spin kit (Genomed, Lohne, Germany). Sanger 157 
sequencing (of all PCR products and plasmids) was performed by MWG Biotech (Eurofins, 158 
Ebersberg, Germany) to verify the integrity of all plasmid constructs and to compare the 159 
sequences of the CRISPR loci of the BIMs to those of the corresponding parent strain. 160 
CRISPRs were assembled using the Seqman program (DNAstar) and the length of the arrays 161 
(as well as spacer number) were determined using the online CRISPR finder program (51). 162 
Detailed analyses of CRISPR repeat/spacer loci (including all BIM-acquired spacer 163 
sequences generated as part of this study) are provided in Supplementary Tables S1, S2 and 164 
S6 - S9. 165 
 166 
Sedimentation, microscopic and adsorption assays 167 
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Relative sedimentation of S. thermophilus parent strains and derived BIMs was observed by 168 
growing (in liquid culture) representatives of each strain or BIM under identical conditions 169 
(as described above). Taking care not to disturb the liquid broth, visual assessment of the 170 
cultures was then performed to observe relevant growth characteristics such as pelleting, 171 
clumping and adherence to the walls of the tubes. In all cases, this assay was performed using 172 
both glass and plastic tubes in order to account for any possible influence of these materials 173 
on observed sedimentation patterns.  174 
Morphological assessment and comparison of parent strains and derived BIMs was 175 
performed via wet mount. 5 µl of fresh overnight culture was placed on a glass slide (in 176 
duplicate) and a cover slip immediately placed on top of the sample. Each sample was then 177 
visualised using 63 X magnification using a confocal laser scanning microscope and a Zeiss 178 
LSM 5 Exciter (Carl Zeiss, Jena, Germany; excitation 488 nm). The percentage increase in 179 
chain length or cells per chain (CPC) of derived BIMs relative to the parent strains was 180 
calculated firstly by determining the average number of individual cells per chain in all 181 
samples by counting at least 20 chains per strain. The average increase in length was then 182 
expressed as a percentage using the following formula: (CPCmutant – CPCparent)/CPCparent x 100 183 
%). In all cases, the unpaired student t-test was used to determine significant differences 184 
between the datasets obtained from the parent and its derived BIMs. 185 
 Adsorption assays were performed as described previously (52), in an adaptation of 186 
the protocol as described in a subsequent publication (53). 187 
 188 
Construction of antisense plasmid vectors 189 
In order to distinguish cas genes associated with distinct CRISPR-Cas systems, a specific 190 
nomenclature was devised which was generally in accordance with a previously described 191 
naming system (34). Where identically named cas genes were found to be associated with 192 
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distinct CRISPR systems on a single bacterial genome, a suffix was added to denote this (for 193 
example, csn2-1 refers to the gene encoding the Csn2 protein associated with the CRISPR1-194 
Cas system in that strain, etc.). The PCR primers used to amplify csn2-1, csn2-3, cas9-1 and 195 
cas9-3 from either STA or STB are listed in Table 2. All primers were designed to 196 
incorporate the entire relevant gene including the Shine-Dalgarno (SD) sequence, with the 197 
exception of those targeting cas9-3, which were designed to incorporate approximately 3 kb 198 
of this gene (of a total gene size of 4167 bp), due to the insert size constraint of plasmid 199 
pNZ44 (this plasmid becomes unstable when large fragments are cloned into it due to the fact 200 
that it is a rolling circle replication plasmid (54)). To ensure that an antisense product was 201 
produced, all cas genes were cloned into the pNZ44 plasmid in the reverse orientation 202 
relative to the p44 promoter (44). In the case of single-gene constructs, the relevant gene was 203 
cloned directly behind the p44 promoter in reverse orientation, whereas in the 2Csni construct 204 
(simultaneously targeting the csn2 genes of both the CRISPR1-Cas and CRISPR3-Cas 205 
systems, i.e. csn2-1 and csn2-3), csn2-1 was cloned directly behind the p44 promoter, 206 
followed by csn2-3, both again in reverse orientation relative to the transcriptional direction 207 
of the p44 promoter. PCR amplifications were described as above using the appropriate 208 
extension time for each gene. PCR product purification and sequencing was performed as 209 
described above. Restriction of plasmid vectors and inserts was performed using the 210 
appropriate restriction enzyme (Roche, Basel, Switzerland) in a total volume of 200 µl 211 
overnight at room temperature (RT). Ligations were performed using T4 DNA ligase (New 212 
England Biolabs, Ipswich, MA, U.S.A.) in a total volume of 10 µl overnight at RT. In 213 
preparing the 2Csni construct, 3 µl of each appropriate insert was used in the ligation 214 
reaction. Antisense constructs used in this study are listed in Table 1. 215 
 216 
Preparation of competent cells, electrotransformation & transformant screening 217 
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Competent cells were prepared as described previously (55), with the following 218 
modifications: a series of tubes containing 10 ml LM17 or GM17 (for L. lactis) broth and 219 
varying (from 0.2 % to 2.4 %) concentrations of threonine (Sigma-Aldrich) were prepared 220 
and inoculated (1 %) with a fresh overnight culture. The tubes were incubated at 42 °C 221 
overnight and examined for growth. LM17 broth containing 0.5 % sucrose (Sigma-Aldrich; 222 
SLM17) supplemented with the highest level of threonine tolerated by the strains was used to 223 
prepare competent cells.  224 
 Prior to transformation, plasmid constructs, prepared using the GeneJet plasmid 225 
Miniprep kit (Thermo Scientific, Waltham, MA, U.S.A.), were dialysed using 0.025 µm MF 226 
membrane filters (Merck Millipore, Billerica, MA, U.S.A.) for 10 mins against sterile 227 
distilled water (sdH2O). All constructs were generated in L. lactis NZ9000 prior to their 228 
subsequent transfer to S. thermophilus STA or STB. Electrotransformation was performed 229 
using freshly prepared competent cells as described above, wherein a mixture of cells (50 µl) 230 
and plasmid construct (10 µl) was transferred to a pre-chilled (on ice) 2 mm electroporation 231 
cuvette (Cell Projects, Kent, U.K.) and subjected to electroporation at 1.75 kV (S. 232 
thermophilus) or 2.0 kV (L. lactis)/200 Ohm/25 µF. Following this, 950 µl recovery broth 233 
(LM17 or GM17 with the addition of 20 mM MgCl2 and 2 mM CaCl2 (Sigma-Aldrich)) was 234 
immediately added and the transformed cells were recovered at 30 °C (L. lactis) or 42 °C (S. 235 
thermophilus) for 2.5 hrs, prior to spread plating (100 µl) on LM17 or GM17 + Cm5 agar 236 
plates as described above. Presumed transformants were purified on LM17 or GM17 + Cm5 237 
agar plates and subjected to CRISPR sequencing, phage sensitivity assays (as described 238 
above) and plasmid sequencing, which was performed using primers designed outside the 239 
MCS of pNZ44 (pNZ44F and pNZ44R; Table 2). 240 
 241 
Plasmid curing 242 
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To cure pNZ44 and pNZ44-derivative vectors from S. thermophilus transformants, such 243 
strains were subjected to at least two overnight passages at 42 °C in LM17 in the absence of 244 
Cm. Overnight cultures were then ten-fold serially diluted in ¼ strength Ringers solution 245 
(Merck), or a culture streak performed, and individual colonies were assessed for sensitivity 246 
to Cm by streaking on LM17+Cm5 agar plates. Colonies incapable of growth on 247 
LM17+Cm5, yet capable of growth in the absence of Cm were defined as presumptive cured 248 
transformants and subjected to validation by CRISPR PCR and plasmid preparation as 249 
described above. In cases where two overnight passages were not sufficient for plasmid 250 
curing (as indicated by the ability to grow on LM17+Cm5), passaging was repeated until 251 
curing was achieved and cured derivatives validated as outlined above.  252 
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Results and Discussion 253 
BIMs of S. thermophilus STA 254 
Generation of CRISPR and non-CRISPR-mediated BIMs of STA 255 
Considering that the two bacterial strains applied in this study were observed to behave 256 
differently when subjected to phage attack, distinct cas silencing approaches were adopted. 257 
For this reason, STA and STB will be discussed separately. BIMs of S. thermophilus STA 258 
(Table 1) were generated by phage exposure, and validated by phage sensitivity assays and 259 
CRISPR locus sequencing (Table 3 and Supplementary Table S1). BIMs of this strain were 260 
readily generated in this manner (occurring at a frequency of approximately 1x10
-5
, estimated 261 
by dividing the cfu/ml of visible BIMs after overnight incubation by the cfu/ml of the 262 
overnight culture used in the plaque assay), and two BIMs (designated STA BIM1 and STA 263 
BIM2; Table 1), both generated against phage 7951, were selected for further 264 
characterisation. The relative efficiencies of plaquing (EOP) of each assessed phage on a 265 
given BIM are given in Table 3. While STA BIM1 was found to be resistant only to the 266 
phage used in the challenge (7951), STA BIM2 was shown to be resistant to all four, 267 
genetically distinct (56), phages available against the parent strain (phages 7951, 7952, 7953 268 
and 7954, here referred to as phages 7951-4, Table 1). In addition, while presumed ‘escape 269 
mutant’ phages were detected on STA BIM1 using the plaque assay method (as indicated by 270 
single, well-formed plaques occurring in the bacterial lawn upon challenge using undiluted 271 
phage lysate), this was not the case for STA BIM2, for which no escape mutants could be 272 
isolated (Table 3). Determination of the sequences of the CRISPR1, 2 and 3 loci of the two 273 
BIMs (CRISPR4 is not detected by PCR and presumed to be absent), and comparison to 274 
those of the parent strain from which they had been derived, showed that STA BIM1 had 275 
acquired a single spacer in the CRISPR1 locus (Supplementary Tables S1 and S7; with 276 
schematic representations of the CRISPR1-Cas and CRISPR3-Cas loci given in Figure 1). 277 
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The sequence of this added spacer displayed 100 % identity to a region on the genome of 278 
phage 7951 (partly located within ORF357951 which encodes a predicted RecT recombinase 279 
(56), consistent with protospacer targeting (30). In contrast, the sequences of the CRISPR1, 2 280 
and 3 loci of STA BIM2 were identical to the parent strain (Supplementary Table S1). Taken 281 
together, these data indicate that the mechanisms by which STA BIM1 and STA BIM2 had 282 
become resistant to phage 7951 were distinct. 283 
 To further characterise the derived BIMs, STA BIM1 and STA BIM2 were subjected 284 
to adsorption (Table 4), sedimentation (Fig. 3) and morphological assays (Fig. 4, Table 5) as 285 
described in the Materials and Methods. Adsorption efficiency of phage 7951 (which was 286 
used in the challenge) on STA BIM1 was not significantly different compared to the parent 287 
strain. Similarly, compared to the parent strain, this BIM did not show a significantly 288 
different sedimentation profile and cell chain length properties, as measured by counting the 289 
number of cells within continuous cell chains in a wet mount preparation of the strain (‘cells-290 
per-chain’ (CPC)). In contrast to this presumed CRISPR-mediated BIM, strain STA BIM2 291 
was shown to exhibit a significant reduction in its ability to adsorb phage 7951, indicating 292 
that a phage receptor modification is responsible for the observed phage insensitivity of this 293 
BIM. Interestingly, this BIM also showed a distinct sedimentation profile relative to the STA 294 
WT (and to STA BIM1), in that cells of STA BIM2 were shown to sediment to the bottom of 295 
the tube used for standard overnight growth, as visualised in Figure 3. Indeed, this 296 
phenomenon has previously been observed in phage adsorption-deficient derivatives of 297 
Lactococcus lactis (57) and is indicative of a bacterial cell surface alteration. Lastly, a 298 
significant increase in cell chain length was observed in STA BIM2 compared to the parent 299 
strain and STA BIM1 (Fig. 4, Table 5), indicative of a cell envelope alteration and consistent 300 
with the observed sedimentation phenotype (58, 59). The nature of these mutations have been 301 
characterised and will be published elsewhere (McDonnell et. al., unpublished data). 302 
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 303 
CRISPR-Cas silencing restores the sensitivity of CRISPR-mediated BIMs to phages  304 
An antisense mRNA silencing approach for CRISPR inactivation in S. thermophilus was 305 
performed to confirm that the observed phage resistance in STA BIM1 was conferred by the 306 
CRISPR-Cas system, in contrast to the phage resistance observed for STA BIM2. To this 307 
end, STA BIM1 and STA BIM2 were transformed using a cas9-interfering (Cas9i) antisense 308 
plasmid construct as described in the Materials and Methods. The constitutive p44 promoter 309 
combined with the cloning, in reverse orientation, of the native STA cas9 gene was employed 310 
to produce cas9-antisense mRNA (partly) complementary to the cas9-encompassing mRNA. 311 
It was reasoned that if this cas9-anti-sense RNA hybridized with its sense counterpart it 312 
would interfere with translation of cas9 mRNA and thus with its associated CRISPR-313 
mediated phage resistance. Table 3 shows the relative EOPs of phages on these ‘CRISPR-314 
silenced’ derivatives. It is clear that when BIM STA BIM1 contains the cas9-anti-sense 315 
producing plasmid (pNZ44+Cas9-1i), phage sensitivity is restored approximately to wild-316 
type (WT) levels, thus demonstrating that this plasmid is capable of effective CRISPR 317 
‘silencing’ by presumed antisense mRNA production. STA BIM1::pNZ44+Cas9-1i was then 318 
subjected to plasmid curing as outlined above. Table 3 shows that, when cured of the 319 
silencing plasmid, the respective phage resistance profile of STA BIM1 was restored to that 320 
observed prior to the introduction of plasmid pNZ44+Cas9-1i. Interestingly, the introduction 321 
of plasmid pNZ44 without insert (as a control), seemed to partially increase the sensitivity of 322 
STA BIM1 to all four phages (Table 3), although this increased sensitivity did not approach 323 
the level of restored sensitivity of STA BIM1::pNZ44+Cas9-1i to phage 7951 using the cas 324 
silencing approach (Table 3). The reason for this phenomenon is unknown.  325 
To confirm that the insensitivity of S. thermophilus STA BIM2 was conferred by a 326 
resistance mechanism other than CRISPR1, plasmid pNZ44+Cas9-1i was introduced to this 327 
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BIM and the resulting strain was then subjected to the phage assays outlined above. It is clear 328 
from Table 3 that silencing the CRISPR1-Cas system had no significant effect on the ability 329 
of phages 7951-4 to produce plaques on this strain, thus supporting the notion that 7951-4 330 
insensitivity in this BIM is not mediated by a CRISPR-Cas system.  331 
 332 
BIMs of S. thermophilus STB 333 
STB predominantly produces CRISPR-mediated BIMs 334 
BIMs of S. thermophilus strain STB were generated and validated by CRISPR locus 335 
sequencing (Supplementary Tables S2, S6, S8 and S9). Phages used in each challenge are 336 
listed in Table 1, and the relative EOP values of each phage on each BIM are given in Table 337 
6. While BIMs with altered and unaltered CRISPR spacer content were readily derived from 338 
strain STA (as described above), all analysed BIMs derived from STB (generally arising at an 339 
approximate frequency of 10
-7
) were shown to contain spacer alterations in either the 340 
CRISPR1 or CRISPR3 loci (Supplementary Tables S3 and S9; Fig. 2). This phenomenon is 341 
illustrated in Supplementary Tables S3 and S9, which shows that 100 % of analysed BIMs 342 
derived from STB WT contained an additional spacer in either locus.  343 
The observation that phage exposure invariably results in the addition of CRISPR 344 
spacers in STB was exploited to produce a BIM containing iterative additions of spacers 345 
acquired upon exposure to previously unencountered phages: STB BIM1 was used to isolate 346 
STB BIM2, having been exposed to phages 9854 and 9851, independently and respectively. 347 
CRISPR spacer content of each BIM relative to parent strain STB is shown in Supplementary 348 
Tables S2 and S8. Successive spacer addition was shown to correspond with phage 349 
insensitivity, i.e. additional spacers conferred resistance to the phage against which the BIM 350 
had been challenged (Table 6, and as previously shown (40)). It is noteworthy that, while 351 
presumed phage CRISPR escape mutants (CEMs) were detected in most cases, phage 9854 352 
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did not produce plaques at a detectable level on STB BIM2. This may be explained by the 353 
fact that the added spacer in the CRISPR1 locus of STB BIM2(added subsequent to challenge 354 
with phage 9851) also shows 100 % nucleotide identity to phage 9854 (already targeted by a 355 
spacer in CRISPR3). It is plausible that the lack of escape mutants is due to the effect of 356 
being targeted by two distinct CRISPR-Cas systems through the addition of these two 357 
spacers, a phenomenon which has previously been observed using a similar approach (40).  358 
 359 
CRISPR-Cas silencing in CRISPR1 and CRISPR3-mediated STB BIMs 360 
To prove the broader feasibility of the silencing method (as outlined above for strain STA), 361 
this approach was adopted in STB derivatives STB BIM1 and STB BIM2, purported to be 362 
CRISPR-mediated BIMs. The EOP values given in Table 6 clearly show that in STB BIM1 363 
harbouring the Cas9-3i construct (or, in the case of STB BIM2, the Cas9-1i construct), 364 
sensitivity to phages used in the initial challenge is largely reverted, where this effect is not 365 
seen in STB BIM1 and STB BIM2 that harbour the control pNZ44 plasmid.  366 
The specificity of this system is highlighted by restoration of the sensitivity of STB 367 
BIM2 to phage 9851 (and not 9854) – indicating that only those phages which had previously 368 
been targeted by the now silenced CRISPR-Cas system regain the ability to infect. In the case 369 
of STB BIM2::pNZ44+Cas9-1i, however, the restoration of sensitivity to phage 9851 is not 370 
complete (the EOP of the phage being approximately 10
-3
 relative to STB WT; Table 6). It is 371 
possible that the silencing protocol was not operating at optimal efficiency, potentially due to 372 
the plasmid being targeted by the CRISPR1 or (more likely, considering the CRISPR1-Cas9-373 
silencing nature of the insert) the CRISPR3-Cas system also being present in this strain.  374 
  375 
CRISPR-Cas silencing reduces the incidence of CRISPR spacer addition during BIM 376 
generation 377 
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Considering the evident spacer addition in analysed BIMs of STB (mentioned above), we 378 
endeavoured to inhibit the generation of CRISPR-mediated BIMs in this strain. For this 379 
purpose, two silencing plasmid constructs were employed separately. The first 380 
(pNZ44+Csn2-1i), was used to target the csn2-1 gene, i.e. the CRISPR1-Cas system only. 381 
The second construct (pNZ44+2Csni) produced a single antisense transcript targeting csn2-1 382 
and csn2-3, i.e. the action of both the CRISPR1-Cas and CRISPR3-Cas systems 383 
simultaneously. The encoded product of csn2-1 has previously been implicated in spacer 384 
acquisition in S. thermophilus (30) as well as other species (37), and it was hypothesised that 385 
csn2-3 encodes a protein of similar function in the CRISPR3-Cas system, based on its 386 
analogous position in the CRISPR3-Cas locus (Fig. 1, Fig. 2, 26, 60). The csn2 genes were 387 
employed for gene silencing purposes in this case (in contrast with cas9 genes in previous 388 
experiments) due to their smaller size, potentially enhancing plasmid stability and enabling 389 
the construction of a tandem construct targeting both systems (for reasons discussed in the 390 
Materials and Methods). These constructs were introduced separately into STB WT 391 
(Supplementary Table S3), after which BIMs were generated against phage 9854.  392 
BIMs derived from STB WT, as well as BIM derivatives from STB containing either 393 
pNZ44, pNZ44+Csn2-1i (targeting CRISPR1) or pNZ44+2Csni (targeting CRISPR1-Cas + 394 
CRISPR3-Cas simultaneously), were then generated. In general, absolute numbers of BIMs 395 
growing in the semi-solid agar were lower when STB containing CRISPR-interfering 396 
constructs pNZ44+Csn2-1i or pNZ44+2Csni were used, compared with STB WT or 397 
STB::pNZ44, though the frequencies of these BIMs were not determined due to the assay-398 
dependent nature of this phenomenon. Following BIM generation, the leader ends 399 
(approximately 500 bp) of CRISPRs 1, 3 and 4 repeat/spacer loci in selected BIMs were 400 
subjected to Sanger sequencing. CRISPR2 repeat/spacer loci were excluded from this 401 
analysis due to its apparent inactivity in this species (26). A summary of BIMs containing 402 
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CRISPR repeat/spacer loci which showed alterations is shown in Supplementary Table S3, 403 
with detailed analysis in Supplementary table S9. It is clear that, while the majority (70 %) of 404 
BIMs generated from the WT strain (and plasmid control) acquired spacers in CRISPR1, 405 
those generated from the WT strain containing the Csn2-1 interfering plasmid (pNZ44+Csn2-406 
1i) appeared unable to do so (Fig. 2B). This is consistent with previously published results in 407 
which csn2-1 was inactivated (30). Interestingly, the majority (60 %) of these 408 
STB::pNZ44+Csn2-1i derived BIMs showed alterations in the CRISPR3 locus, indicating an 409 
increase in the ratio of CRISPR3-mediated BIMs (to CRISPR1-mediated BIMs), in the event 410 
of a non-functioning CRISPR1 (Fig 2B). This increase in ratio is reflected in the detection of 411 
CRISPR3-mediated BIMs derived from the STB WT::pNZ44+Csn2-1i strain (Supplementary 412 
Table S9). 413 
 A total of 33 % of BIMs generated using STB WT::pNZ44+Csn2-1i (harbouring a 414 
CRISPR1-interfering plasmid construct) showed no alterations in either of the two analysed 415 
CRISPR loci, demonstrating that the generation of non-CRISPR-mediated BIMs was possible 416 
in this strain using this method (Supplementary tables S3 and S9). 50 % of BIMs generated 417 
using the WT strain harbouring the pNZ44+2Csni construct (targeting both the CRISPR1-Cas 418 
and CRISPR3-Cas systems; Fig. 2C) showed no alterations in any CRISPR locus, indicating 419 
that this construct may be more effective in reducing the acquisition of CRISPR spacers in 420 
response to phages in strain STB. One of the BIMs (designated here as STB BIM3) generated 421 
using this silencing construct was subjected to further characterisation by CRISPR 422 
sequencing (Supplementary Table S2), phage sensitivity assays (Supplementary Table S4) 423 
and adsorption assays (Supplementary Table S5). This BIM, despite lacking additional 424 
spacers in any CRISPR locus, exhibited a reduction in sensitivity to phages 9851 and 9854 425 
(both cos-containing phages), while remaining sensitive to 9853 (a pac-containing phage; 426 
Supplementary Table S4). This BIM can be said to have a wider ranging phage resistance 427 
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profile relative to first generation CRISPR-mediated BIMs STA BIM1 and STB BIM1, 428 
though the reduction in the EOP of phages 9851 and 9854 is slightly less than that exhibited 429 
by the CRISPR-based immunity of STB BIM1 to 9854. STB BIM3 was also shown to adsorb 430 
phage 9854 at an approximately 20 % reduced level (compared to the wild type strain; 431 
Supplementary Table S5). Despite this decrease in adsorption level, this result was not 432 
statistically significant, rendering us unable to define STB BIM3 as an adsorption deficient 433 
BIM. Nonetheless, in the absence of CRISPR spacer addition as an explanation for the 434 
reduction in phage sensitivity (Supplementary table S2 and S4), STB BIM3 may be defined 435 
as a non-CRISPR-mediated BIM, establishing the proof of principle of non-CRISPR BIM 436 
generation in S. thermophilus using the above described silencing protocol. 437 
  438 
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Conclusions 439 
Several mechanisms of phage resistance have been described in S. thermophilus, with the 440 
CRISPR-Cas system being by far the most widely studied. The level of detailed research into 441 
these systems has confirmed their integral role in the resistance S. thermophilus to 442 
bacteriophages (26, 29, 30, 39, 43) and has now progressed to the characterisation of so-443 
called ‘anti CRISPR proteins’ expressed by certain phages (61).  444 
 Mills and colleagues (62) generated a selection of BIMs, wherein CRISPR alteration 445 
was observed to be an unpredictable process, with different numbers of spacers being 446 
acquired (or deleted; indicating an inherent instability in the system) in the same strain - even 447 
when similar phages were used in the challenge.  This unpredictability as well as the response 448 
of the phages to CRISPR spacer acquisition – namely, the modification of single nucleotides 449 
on the phage genomes in order to escape CRISPR targeting (40, 42), suggests that further 450 
phage robustness may be achieved by utilising other phage resistance mechanisms present in 451 
S. thermophilus (in combination with CRISPR). Indeed, this has been shown to be extremely 452 
effective in S. thermophilus by Dupuis and colleagues using a representative strain 453 
(DGCC7710; 43). The purpose of the present study was to develop a useful tool which can be 454 
utilised to select non-CRISPR-mediated BIMs, which may not be possible using standard 455 
BIM generation methods due to the inherent activity of the system. 456 
The cas9/csn2 silencing method outlined herein was successful in preventing spacer 457 
acquisition in CRISPR loci during standard BIM generation experiments. Introducing a 458 
CRISPR1-associated csn2-1 targeting plasmid in STB resulted in 66 % of BIMs characterised 459 
having acquired spacers in CRISPR3 (and none in CRISPR1), a clear increase in the 460 
detection of CRISPR-3-mediated BIMs, compared to those BIMs produced by the WT strain 461 
(of which 90 % showed spacer acquisition in the CRISPR1 repeat/spacer locus). To eliminate 462 
or at least reduce CRISPR spacer acquisition in either system, it was therefore necessary to 463 
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target both csn2-1 and csn2-3 using a combinatory, anti-sense-mediated silencing plasmid 464 
construct. While a number of CRISPR1 spacer acquisitions were detected using this construct 465 
(possibly due to the increased competition for the resultant antisense mRNA transcript), 466 
employing this method also resulted in the production of a number of apparently non-467 
CRISPR-mediated BIMs. 468 
In this study we present data relating to the generation and characterisation of non-469 
CRISPR-mediated BIMs, specifically, those mediated by an apparent adsorption inhibition 470 
mechanism. The nature of phage receptors in S. thermophilus have been characterised, and 471 
proposed to be carbohydrate in nature (63, 64). BIMs which are deficient in phage adsorption 472 
have previously been described, having been selected by immuno-labelling followed by flow 473 
cytometry (65), mutant library construction followed by phage challenge (7), or by chemical 474 
mutagenesis (13). However, these BIMs were not described as having the phenotypic 475 
characteristics of the adsorption-deficient BIMs described above, namely sedimentation and 476 
increased cell chain length. The non-CRISPR-mediated BIMs generated in this study 477 
displayed some advantages over CRISPR-mediated BIMs, in that they were either resistant to 478 
a wider range of phages, or to a higher level (with no phage escape mutants being observed 479 
during standard plaque assays using STA BIM2). It has furthermore been shown previously 480 
that S. thermophilus BIMs mediated by both CRISPR and a restriction/modification (R/M) 481 
system are resistant to high levels of phages (43), and it was speculated that CRISPR-Cas 482 
systems combined with other antiphage mechanisms also exhibit highly protective effects 483 
(also suggested by Viscardi et al. (65).  484 
The method of BIM generation described above offers a number of advantages over 485 
traditional methods of derivation. Firstly, no specialised equipment or chemical mutagenesis 486 
is required for its implementation. While the method relies on RNA silencing through 487 
plasmid transformation in order to decrease the activity of the CRISPR system(s), the plasmid 488 
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may be removed prior to industrial implementation. Additionally, the use of antibiotic 489 
selection is not required once BIM generation has been carried out. This method may also be 490 
used to bias the addition of CRISPR spacers towards either the CRISPR1 or CRISPR3 491 
repeat/spacer loci. This may reduce the risk of spacer deletion or replacement in second 492 
generation CRISPR BIMs, a process which is thought to function in eliminating older (and 493 
therefore less useful) spacers, limiting the size of the CRISPR loci (26, 62). In the case of a 494 
hypothetical population of BIMs in which the mechanism of resistance is unknown, this 495 
method may also be used to rapidly determine if phage insensitivity is conferred by the 496 
CRISPR-Cas system alone or by a combination of mechanisms. Lastly, this method may be 497 
employed to generate a diverse collection of S. thermophilus BIMs which have become 498 
resistant to phage by distinct mechanisms of action, for use in industrial strain blends or 499 
rotational schemes.  500 
 501 
  502 
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Figure legends 503 
 504 
Figure 1. Schematic representation of the CRISPR1-Cas and CRISPR3-Cas systems of 505 
S. thermophilus STA. 506 
 507 
Figure 2. CRISPR spacer addition patterns in STB WT (A), STB::pNZ44+Csn2-1i (B) 508 
and STB::pNZ44+2Csni (C). 509 
 510 
Figure 3. Observed sedimentation of S. thermophilus STA parent strain and derived BIMs. 511 
(A) STA WT, (B) STA BIM1 (CRISPR BIM), (C) STA BIM2 (non-CRISPR BIM), where (i) 512 
indicates a partial clearing of the supernatant broth and (ii) indicates a visible increase in 513 
pellet size. 514 
 515 
Figure 4. Representative images of cell chains visualised using a confocal laser scanning 516 
microscopy. (A) STA WT, (B) STA BIM1 (CRISPR BIM), (C) STA BIM2 (non-CRISPR 517 
BIM). 518 
 519 
 520 
 521 
 522 
  523 
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Table 1. Bacterial strains and bacteriophages applied during this study.  738 
 739 
Strain / Phage / Plasmid Description Source 
S. thermophilus strains   
   STA  Industrial starter parent strain DSM, Delft, The Netherlands 
   STB Industrial starter parent strain “ 
   STA BIM1 CRISPR-BIM of STA generated against phage 7951 UCC, Cork, Ireland 
   STA BIM2STA BIM2 Non-CRISPR BIM of STA generated against phage 7951 “ 
   STB BIM1 CRISPR-BIM of STB generated against phage 9854 “ 
   STB BIM2 CRISPR-BIM derivative of STB generated against phage 9851 “ 
   STB BIM3 Non-CRISPR BIM of STB generated against phage 9854 “ 
   
L. lactis strains   
   NZ9000 Transformation host (49) 
   
Phages   
   7951 Lytic pac-containing phage infecting STA DSM, Delft, The Netherlands 
   7952 “ “ 
   7953 “ “ 
   7954 “ “ 
   9851 Lytic cos-containing phage infecting STB “ 
   9853 Lytic pac-containing phage infecting STB “ 
   9854 Lytic cos-containing phage infecting STB “ 
   
Plasmid constructs   
   pNZ44 Transformation vector  
   pNZ44+Cas9-1i STA CRISPR1-Cas9 silencing vector This study 
   pNZ44+Cas9-1i STB CRISPR1-Cas9 silencing vector “ 
   pNZ44+Cas9-3i STB CRISPR3-Cas9 silencing vector “ 
   pNZ44+Csn2-1i STB CRISPR1-Csn2 silencing vector “ 
   pNZ44+2Csni STB CRISPR1-Csn2 and CRISPR3-Csn2 silencing vector “ 
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Table 2. PCR primers applied during this study. Incorporated restriction sites, where applicable, are underlined. Internal ‘gap closing’ primers 740 
are indicated by a ‘g’, and have been applied to all derivatives of the indicated parent S. thermophilus strain. 741 
 742 
Primer name Sequence (5’ -  3’) Target Size of product (approx; bp) Source 
pNZ44F CTAATGTCACTAACCTGCCCCG pNZ44 MCS Template-dependent This study 
pNZ44R GCTTTATCAACTGCTGCT “ “ “ 
STACas9iF AGCAGCTCTAGAGTCGTTAGAGGGAGGATTAC STA Cas9 3366 “ 
STACas9iR AGCAGCCTGCAGTTAAAAATCTAGCTTAGGC “  “ 
STBCas9-1iF AGCAGCTCTAGAGTTGCGAATTTTCAGATAC STB CRISPR1-Cas9 3366 “ 
STBCas9-1iR AGCAGCCTGCAGGTAACTGTGTAAGGCGCC “  “ 
STBCas9-3iF AGCAGCCTGCAGAAGGAGAAATGTATGACTAAG STB CRISPR3-Cas9 4167 “ 
STBCas9-3iR AGCAGCCCATGGCTGGCTCTAGTTTAGGGTATT “  “ 
STBCsn2-1iF AGCAGCCTGCAGCAGTGATAATAAGTTGGTGGT STB CRISPR1-Csn2  1053 “ 
STBCsn2-1iR AGCAGCCCATGGCTGTCCTTGTCAATCCTTAC ”  “ 
STBCsn2-3iF AGCAGCTCTAGAGCCAATTCAGAGGAAAGG STB CRISPR3-Csn2 660 “ 
STBCsn2-3iR AGCAGCCTGCAGCAAGATGTGACTGTCACC ”  “ 
     
CRISPR1F TGCTGAGACAACCTAGTCTCTC CRISPR1 repeat/spacer loci Template-dependent (26) 
CRISPR1R TAAACAGAGCCTCCCTATCC “ “ “ 
CRISPR2F TTAGCCCCTACCATAGTGCTG CRISPR2 repeat/spacer loci “ “ 
CRISPR2R TAGTCTAACACTTTCTGGAAGC “ “ “ 
CRISPR3F CTGAGATTAATAGTGCGATTACG CRISPR3 repeat/spacer loci “ “ 
CRISPR3R GCTGGATATTCGTATAACATGTC “ “ “ 
CRISPR4F GATTCAGTTCCTCATAGAGC CRISPR4 repeat/spacer locus “ This study 
CRISPR4R GACCTCAACCAATCGATTG “ “ “ 
AC1g1 (internal) CCTGTCATCTCTGGGAGT STA CRISPR1 N/A “ 
AC1g2 (internal) CGGTGTTCTATATCGAGGTC “ “ “ 
AC1g3 (internal) GTGAATGGGAAACTGACGGAA “ “ “ 
AC3g1 (internal) CAATCCGTAGCCACACCT STA CRISPR3 “ “ 
BC1g1 (internal) CACTTGGCAGGCTTATTACTC STB CRISPR1 “ “ 
BC1g2 (internal) CATCCGGTAACTGCTCAAGTG “ “ “ 
 743 
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 744 
 745 
Table 3. Relative efficiencies of plaquing (EOPs) of four phages on STA, its derived BIMs 746 
and their CRISPR-Cas silenced derivatives. Values preceded by ‘≤’ indicate the limit of 747 
detection of phage titer.  748 
 749 
 7951 7952 7953 7954 
STA WT 1 1 1 1 
     
STA BIM1 8.33 (± 0.12) x 10
-8
 0.55 ± 0.16 0.75 ± 0.28 0.84 ± 0.49 
STA BIM1::pNZ44 4.87 (± 0.61) x 10
-6
 4.95 ± 1.10 6.02 ± 0.68 6.33 ± 1.90 
STA BIM1::pNZ44+Cas9-1i 1.03 ± 0.07 1.08 ± 0.27 0.93 ± 0.07 1.43 ± 0.30 
STA BIM1::pNZ44+Cas9-1i (cured) 2.21 (± 3.00) x 10
-6
 4.08 ± 3.50 4.04 ± 2.76 3.89 ± 3.41 
     
STA BIM2 ≤ 3 x 10-7 ≤ 1 x 10-8 ≤ 4 x 10-8 ≤ 9 x 10-7 
STA BIM2::pNZ44+Cas9-1i ≤ 3 x 10-7 ≤ 4 x 10-7 1.85 (± 2.62) x 10-7 ≤ 4 x 10-7 
 750 
 751 
 752 
 753 
 754 
Table 4. Adsorption analysis of S. thermophilus parent strains and derived BIMs. 755 
 756 
Strain/BIM Adsorption of phage 7951 (%) p-value 
STA WT 79.9 ± 13.6  
STA BIM1 83.2 ± 1.8 0.76 
STA BIM2 10.2 ± 8.2 0.0034 
 757 
 758 
 759 
Table 5. Relative cells per chain (CPC) of S. thermophilus parent strains and derived BIMs. 760 
 761 
Strain CPC (cells) % CPC average versus parent p-value 
STA (parent) 10.84 ± 8.64 (n=28) N/A N/A 
STA BIM1 7.4 ± 8.30 (n=32) 68.3 0.12 
STA BIM2 25.9 ± 13.0 (n=51) 238.9 3.9 x 10
-5
 
 762 
 763 
Table 6. Efficiencies of plaquing (EOPs) of phages 9851, 9853 and 9854 on STB, its derived 764 
BIMs and their CRISPR-Cas silenced derivatives. Values preceded by ‘≤’ indicate the limit 765 
of detection of phage titer.  766 
 767 
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 768 
 9851 9853 9854 
STB WT 1 1 1 
    
STB BIM1 0.22 ± 0.09 0.26 ± 0.06 2.04 (± 0.79) x 10
-6
 
STB BIM1::pNZ44 0.27 ± 0.06 0.30 ± 0.09 4.01 (± 0.79) x 10
-6
 
STB BIM1::pNZ44+Cas9-3i 2.35 ± 0.33 1.15 ± 0.24 0.22 ± 0.08 
    
STB BIM2 9.80 (± 5.93) x 10
-7
 0.13 ± 0.05 ≤ 1 x 10-9 
STB BIM2::pNZ44 2.59 (± 1.04) x 10
-6
 0.23 ± 0.08 ≤ 1 x 10-9 
STB BIM2::pNZ44+985Cas9-1i 0.002 ± 0.0002 0.56 ± 0.17 ≤ 1 x 10-9 
 769 
 770 
 771 
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